(19)
(11) EP 1 135 180 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.08.2007 Bulletin 2007/32

(45) Mention of the grant of the patent:
09.05.2007 Bulletin 2007/19

(21) Application number: 00970509.6

(22) Date of filing: 29.09.2000
(51) International Patent Classification (IPC): 
A61M 1/02(2006.01)
A61M 1/36(2006.01)
 A61M 1/30(2006.01)
(86) International application number:
PCT/US2000/026738
(87) International publication number:
WO 2001/024848 (12.04.2001 Gazette 2001/15)

(54)

EXTRACORPOREAL BLOOD PROCESSING APPARATUS

VORRICHTUNG ZUR EXTRAKORPORALEN BLUTBEHANDLUNG

APPAREIL DE FRACTIONNEMENT EXTRACORPOREL DU SANG

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 01.10.1999 US 157360 P
27.09.2000 US 672519

(43) Date of publication of application:
26.09.2001 Bulletin 2001/39

(60) Divisional application:
06024296.3 / 1749546

(73) Proprietor: Gambro BCT, Inc.
Lakewood, CO 80215 (US)

(72) Inventor:
  • GIBBS, Bruce, W.
    Arvada, CO 80005 (US)

(74) Representative: Roberts, Mark Peter et al
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)


(56) References cited: : 
EP-A- 0 852 151
DE-A- 4 022 700
US-A- 5 451 321
US-A- 5 836 934
 WO-A-99/11305
US-A- 5 269 946
US-A- 5 527 472
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).